Teva Pharma (TEVA)

Company Ticker Sector | Industry Quality PAR
Teva Pharma TEVA Healthcare | Drugs (Specialty & Generic) 30 5.0%
Current Price (02/27) $12.21
CAPS Rating (Rate this stock on CAPS) Foolcaps 4
Expected Income Statement
Current Sales 17,455.0
Sales Growth Forecast 0.2%
Net Profit Margin 15.1%
Projected Shares Outstanding 1,116.67
EPS - Five year Forecast $2.38
Average P/E Ratio 6.6
Projected Average Price $15.61
Price Appreciation (Annualized) 5.0%
Annual Dividend Yield 0.0%
Projected Annual Return 5.0%
Quality
Financial Strength 31 7.6
EPS Stability 56 14.1
Industry Sales Growth Rate 9.5% 0.2
Industry Net Profit Margin 17.0% 11.1
Calculated Quality Rating 33.1
Fool CAPS

Total Players

2258 Outperforms
79 Underperforms
 

All-Stars (290)

279 Outperforms (96%)
11 Underperforms
 
Fundamental Data Updated: 01/03/2020

MIPAR 10.8%  
Sweet Spot 15.8% - 20.8%  

Top In Drugs (Specialty & Generic)

Ticker Quality PAR
PCRX 60 17.2%
ZTS 73 6.8%
AMPH 41 11.8%
SUPN 28 14.9%
AGN 67 4.0%

Top In Healthcare

Ticker Quality PAR
ALGN 98 19.6%
JAZZ 95 19.2%
ABBV 91 19.2%
UNH 96 15.8%
REGN 81 18.8%